ATE101514T1 - Verwendung von 4-substituierten-imidazolderivaten in der perioperativen medikation. - Google Patents
Verwendung von 4-substituierten-imidazolderivaten in der perioperativen medikation.Info
- Publication number
- ATE101514T1 ATE101514T1 AT89301866T AT89301866T ATE101514T1 AT E101514 T1 ATE101514 T1 AT E101514T1 AT 89301866 T AT89301866 T AT 89301866T AT 89301866 T AT89301866 T AT 89301866T AT E101514 T1 ATE101514 T1 AT E101514T1
- Authority
- AT
- Austria
- Prior art keywords
- perioperative
- medication
- substituted
- imidazole derivatives
- imidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8804683A GB2215206B (en) | 1988-02-29 | 1988-02-29 | 4-substituted imidazole derivatives useful in perioperative care |
| EP89301866A EP0331374B1 (de) | 1988-02-29 | 1989-02-24 | Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE101514T1 true ATE101514T1 (de) | 1994-03-15 |
Family
ID=10632543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89301866T ATE101514T1 (de) | 1988-02-29 | 1989-02-24 | Verwendung von 4-substituierten-imidazolderivaten in der perioperativen medikation. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0331374B1 (de) |
| JP (1) | JP2856410B2 (de) |
| KR (1) | KR0136790B1 (de) |
| AT (1) | ATE101514T1 (de) |
| AU (1) | AU611262B2 (de) |
| CA (1) | CA1338556C (de) |
| DE (1) | DE68913054T2 (de) |
| DK (1) | DK175282B1 (de) |
| GB (1) | GB2215206B (de) |
| HU (1) | HU202751B (de) |
| IE (1) | IE60538B1 (de) |
| NZ (1) | NZ228125A (de) |
| ZA (1) | ZA891493B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI894911A0 (fi) * | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| GB9111732D0 (en) * | 1991-05-31 | 1991-07-24 | Orion Yhtymae Oy | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs |
| GB2281206A (en) * | 1993-08-25 | 1995-03-01 | Orion Yhtymae Oy | Use of dexmedetomidine |
| RU2157210C2 (ru) * | 1995-12-28 | 2000-10-10 | Проктер энд Гэмбл Компани | Замещенные 6h-1,3,4-тиадиазин-2-амины, их применение в качестве анестезирующих, сердечно-сосудистых и гипометаболических средств и содержащие их фармацевтические композиции |
| EP0877025B1 (de) * | 1995-12-28 | 2001-10-17 | The Procter & Gamble Company | Substituierte 6-h-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetisierende cardiovaskulare und hypometabole mittel, und eine sie enthaltende pharmazeutische zubereitung |
| EP0877024B1 (de) | 1995-12-28 | 2002-02-20 | Nauchno-Tekhnologicheskoe Predpriyatie "Ligand" (Obschestvo S Ogranichennoi Otvetstvennostju) | Substituierte 6-h-1,3,4,-thiadiazin-2-amine, deren verwendung als anaesthetisierende, cardiovaskulare und hypometabolische mittel, und eine sie enthaltende pharmazeutische zubereitung |
| AU5127996A (en) * | 1995-12-28 | 1997-07-28 | Procter & Gamble Company, The | Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| AR015744A1 (es) * | 1998-04-01 | 2001-05-16 | Orion Corp | Uso de dexmedetomidina para sedacion en terapia intensiva |
| RU2008130448A (ru) | 2006-01-27 | 2010-03-10 | Ф. Хоффманн-Ля Рош Аг (Ch) | Применение производных 4-имидазола для расстройств цнс |
| RU2009112496A (ru) | 2006-10-19 | 2010-11-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Аминометил-4-имидазолы |
| CA2668454A1 (en) | 2006-11-02 | 2008-05-08 | F. Hoffmann-La Roche Ag | Substituted 2-imidazoles |
| JP2010510184A (ja) | 2006-11-16 | 2010-04-02 | エフ.ホフマン−ラ ロシュ アーゲー | 置換4−イミダゾール類 |
| CA2672617A1 (en) | 2006-12-13 | 2008-06-19 | F. Hoffmann-La Roche Ag | Novel 2-imidazoles as ligands for trace amine associated receptors (taar) |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| CN101600700B (zh) | 2007-02-02 | 2013-08-21 | 弗·哈夫曼-拉罗切有限公司 | 作为taar1配体用于cns病症的新的2-氨基噁唑啉 |
| KR101222412B1 (ko) | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Taar1 리간드로서의 2-아미노옥사졸린 |
| CN101687812A (zh) | 2007-07-02 | 2010-03-31 | 弗·哈夫曼-拉罗切有限公司 | 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物 |
| CA2691704A1 (en) | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| CA2694362A1 (en) | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| JP5341084B2 (ja) | 2007-08-03 | 2013-11-13 | エフ.ホフマン−ラ ロシュ アーゲー | Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体 |
| US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| ES2733905T3 (es) * | 2009-02-13 | 2019-12-03 | Allergan Inc | Composiciones farmacéuticas que comprenden (3-(1-(1H-imidazol-4-il)etil)-2-metilfenil)metanol |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| AU2012340806B2 (en) | 2011-11-21 | 2017-10-19 | Allergan, Inc. | Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases |
| CA2924236C (en) | 2013-10-07 | 2020-01-07 | Teikoku Pharma Usa, Inc. | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine |
| KR101948779B1 (ko) | 2013-10-07 | 2019-05-21 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법 |
| CA2924233C (en) | 2013-10-07 | 2018-10-23 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions |
| CN108713019B (zh) | 2016-03-17 | 2021-06-15 | 豪夫迈·罗氏有限公司 | 具有作为taar的激动剂的活性的5-乙基-4-甲基-吡唑-3-甲酰胺衍生物 |
| BR112019006955A2 (pt) | 2016-10-31 | 2019-07-02 | Teikoku Pharma Usa Inc | métodos de controle da dor usando dispositivos de distribuição transdérmica de dexmedetomidina |
| US12472158B2 (en) | 2019-02-27 | 2025-11-18 | Vanderbilt University | Methods of treating trigeminal nerve pain |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3202660A (en) | 1961-10-09 | 1965-08-24 | Boehringer Sohn Ingelheim | Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes |
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| FI844786A0 (fi) * | 1984-12-04 | 1984-12-04 | Farmos Oy | Terapeutiskt utnyttjbar foerening. |
| FI864570A0 (fi) * | 1986-11-11 | 1986-11-11 | Farmos Oy | Terapeutiskt anvaendbar foerening. |
| GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
-
1988
- 1988-02-29 GB GB8804683A patent/GB2215206B/en not_active Expired - Fee Related
-
1989
- 1989-02-02 DK DK198900464A patent/DK175282B1/da not_active IP Right Cessation
- 1989-02-23 AU AU30272/89A patent/AU611262B2/en not_active Expired
- 1989-02-24 NZ NZ228125A patent/NZ228125A/en unknown
- 1989-02-24 EP EP89301866A patent/EP0331374B1/de not_active Expired - Lifetime
- 1989-02-24 AT AT89301866T patent/ATE101514T1/de not_active IP Right Cessation
- 1989-02-24 DE DE68913054T patent/DE68913054T2/de not_active Expired - Fee Related
- 1989-02-27 HU HU89917A patent/HU202751B/hu not_active IP Right Cessation
- 1989-02-27 KR KR1019890002361A patent/KR0136790B1/ko not_active Expired - Lifetime
- 1989-02-27 JP JP1048391A patent/JP2856410B2/ja not_active Expired - Lifetime
- 1989-02-27 ZA ZA891493A patent/ZA891493B/xx unknown
- 1989-02-28 IE IE63989A patent/IE60538B1/en not_active IP Right Cessation
- 1989-02-28 CA CA000592371A patent/CA1338556C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HUT51139A (en) | 1990-04-28 |
| ZA891493B (en) | 1989-11-29 |
| HU202751B (en) | 1991-04-29 |
| EP0331374A2 (de) | 1989-09-06 |
| JP2856410B2 (ja) | 1999-02-10 |
| GB2215206A (en) | 1989-09-20 |
| DE68913054D1 (de) | 1994-03-24 |
| EP0331374A3 (en) | 1990-10-10 |
| DK46489A (da) | 1989-08-30 |
| KR890012647A (ko) | 1989-09-18 |
| CA1338556C (en) | 1996-08-27 |
| KR0136790B1 (ko) | 1998-04-25 |
| DK46489D0 (da) | 1989-02-02 |
| GB2215206B (en) | 1991-07-03 |
| EP0331374B1 (de) | 1994-02-16 |
| DK175282B1 (da) | 2004-08-09 |
| JPH01294623A (ja) | 1989-11-28 |
| IE60538B1 (en) | 1994-07-27 |
| IE890639L (en) | 1989-08-29 |
| DE68913054T2 (de) | 1994-07-07 |
| NZ228125A (en) | 1996-12-20 |
| GB8804683D0 (en) | 1988-03-30 |
| AU611262B2 (en) | 1991-06-06 |
| AU3027289A (en) | 1989-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE101514T1 (de) | Verwendung von 4-substituierten-imidazolderivaten in der perioperativen medikation. | |
| DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
| DK0726899T3 (da) | Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler | |
| DE69230013D1 (de) | Fibrinogen-Rezeptor-Antagonisten | |
| DE69224552D1 (de) | Fibrinogen-Rezeptor-Antagonisten | |
| ATE216360T1 (de) | Sulfinsäurederivate und deren herstellung und verwendung | |
| KR870700611A (ko) | 질소함유 헤테로고리 화합물 | |
| DE3780618D1 (de) | Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses. | |
| DE59407431D1 (de) | Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten | |
| MY102323A (en) | New ribofuranuronic acid derivatives | |
| ATE102191T1 (de) | Substituierte 4-(1h-imidazol-1-yl>benzamide als antiarrhythmische mittel. | |
| ATE191317T1 (de) | Verwendung von beta-aminopropionsäure-derivaten als fungizide | |
| PH25106A (en) | 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof | |
| DE3876536D1 (de) | Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung. | |
| DE59106201D1 (de) | Dermatologische Zusammensetzungen mit einem Gehalt an cis-Urocaninsäure. | |
| ATE116854T1 (de) | Verwendung von buspiron in schlaf-apnoe. | |
| DE59508900D1 (de) | Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide | |
| ATE92318T1 (de) | Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel. | |
| IL87561A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| ATE122886T1 (de) | Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht. | |
| NO303825B1 (no) | Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene | |
| DE68918651D1 (de) | Verwendung von Imidazopyrazolderivaten als analgesische und antiinflammatorische Mittel. | |
| ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre | |
| ATE66921T1 (de) | Verwendung von triazolylderivate zur bekaempfung von pilzen. | |
| DE3874361D1 (de) | Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |